Terms: = Head and neck cancer AND CDC73, HRPT2, 79577, ENSG00000134371, HPT-JT, Q6P1J9, FLJ23316, C1orf28
198 results:
1. Parathyroid tumors in the 5th edition of the WHO Classification of Tumors of the Endocrine Organs.
J D
Cesk Patol; 2024; 60(1):68-70. PubMed ID: 38697830
[TBL] [Abstract] [Full Text] [Related]
2. Insights into Hyperparathyroidism-Jaw Tumour Syndrome: From Endocrine Acumen to the Spectrum of
Gheorghe AM; Sima OC; Florescu AF; Ciuche A; Nistor C; Sandru F; Carsote M
Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396977
[TBL] [Abstract] [Full Text] [Related]
3. A family case report of parathyroid carcinoma associated with
Gu Y; Ye Y; Shu H; Chang L; Xie Y; Li F; Zhu T; Liu M; He Q
Front Endocrinol (Lausanne); 2024; 15():1330185. PubMed ID: 38348418
[TBL] [Abstract] [Full Text] [Related]
4. Generation of induced pluripotent stem cell line (MIPTi002-A) derived from a patient with a heterozygous type mutation in the cdc73 gene.
Alsalloum A; Asaad W; Krupinova J; Kegeles E; Sirotkina P; Panova A; Mityaeva O; Volchkov P
Stem Cell Res; 2024 Mar; 75():103311. PubMed ID: 38237426
[TBL] [Abstract] [Full Text] [Related]
5. Brown tumor due to primary hyperparathyroidism in a familial case: a case report.
Diao Z; Zhang J; Zhao J; Sun W; Pu Z
BMC Endocr Disord; 2023 Oct; 23(1):214. PubMed ID: 37807045
[TBL] [Abstract] [Full Text] [Related]
6. Approach to the Patient With Parathyroid Carcinoma.
Cetani F; Pardi E; Torregrossa L; Borsari S; Pierotti L; Dinoi E; Marcocci C
J Clin Endocrinol Metab; 2023 Dec; 109(1):256-268. PubMed ID: 37531615
[TBL] [Abstract] [Full Text] [Related]
7. Phenotypic Profiling and Molecular Mechanisms in Hyperparathyroidism-jaw Tumor Syndrome.
Tora R; Welch J; Sun J; Agarwal SK; Bell DA; Merino M; Weinstein LS; Simonds WF; Jha S
J Clin Endocrinol Metab; 2023 Nov; 108(12):3165-3177. PubMed ID: 37339334
[TBL] [Abstract] [Full Text] [Related]
8. Parathyroid carcinoma: molecular therapeutic targets.
Marini F; Giusti F; Palmini G; Aurilia C; Donati S; Brandi ML
Endocrine; 2023 Sep; 81(3):409-418. PubMed ID: 37160841
[TBL] [Abstract] [Full Text] [Related]
9. Genomic and transcriptomic profiling reveal molecular characteristics of parathyroid carcinoma.
Jo SY; Hong N; Lee S; Jeong JJ; Won J; Park J; Kim GJ; Kim SK; Kim S; Rhee Y
Exp Mol Med; 2023 May; 55(5):886-897. PubMed ID: 37121965
[TBL] [Abstract] [Full Text] [Related]
10. Germline- and Somatic-Inactivating FLCN Variants in Parathyroid cancer and Atypical Parathyroid Tumors.
Jha S; Welch J; Tora R; Lack J; Warner A; Del Rivero J; Sadowski SM; Nilubol N; Schmidt LS; Linehan WM; Weinstein LS; Simonds WF; Agarwal SK
J Clin Endocrinol Metab; 2023 Sep; 108(10):2686-2698. PubMed ID: 36935552
[TBL] [Abstract] [Full Text] [Related]
11. Genomic Profiling of the Craniofacial Ossifying Fibroma by Next-Generation Sequencing.
Bahceci DH; Grenert JP; Jordan RCK; Horvai AE
Head Neck Pathol; 2023 Sep; 17(3):722-730. PubMed ID: 36928741
[TBL] [Abstract] [Full Text] [Related]
12. Familial parathyroid tumours-comparison of clinical profiles between syndromes.
Figueiredo AA; Saramago A; Cavaco BM; Simões-Pereira J; Leite V
J Endocrinol Invest; 2023 Sep; 46(9):1799-1806. PubMed ID: 36780067
[TBL] [Abstract] [Full Text] [Related]
13. Clinical and genetic analysis of atypical parathyroid adenoma compared with parathyroid carcinoma and benign lesions in a Chinese cohort.
Chen Y; Song A; Nie M; Jiang Y; Li M; Xia W; Wang O; Xing X
Front Endocrinol (Lausanne); 2023; 14():1027598. PubMed ID: 36777354
[TBL] [Abstract] [Full Text] [Related]
14. Para This, Fibromin That: The Role of cdc73 in Parathyroid Tumors and Familial Tumor Syndromes.
Ababneh E; Nosé V
Surg Pathol Clin; 2023 Mar; 16(1):97-105. PubMed ID: 36739170
[TBL] [Abstract] [Full Text] [Related]
15. Innate differences in the molecular signature of normal inferior & superior human parathyroid glands: potential implications for parathyroid adenoma.
Agarwal S; Kar P; Boruah M; Saha S; Millo T; Kumar C; Vuthaluru S; Goswami R
Mol Cell Biochem; 2023 Oct; 478(10):2351-2359. PubMed ID: 36703095
[TBL] [Abstract] [Full Text] [Related]
16. Diagnosis and management of parathyroid carcinoma: a state-of-the-art review.
Roser P; Leca BM; Coelho C; Schulte KM; Gilbert J; Drakou EE; Kosmas C; Ling Chuah L; Wassati H; Miras AD; Crane J; Aylwin SJB; Grossman AB; Dimitriadis GK
Endocr Relat Cancer; 2023 Apr; 30(4):. PubMed ID: 36621911
[TBL] [Abstract] [Full Text] [Related]
17. Genomic Profiling Reveals the Variant Landscape of Sporadic Parathyroid Adenomas in Chinese Population.
Tao X; Xu T; Lin X; Xu S; Fan Y; Guo B; Deng X; Jiao Q; Chen L; Wei Z; Chen C; Yang W; Zhang Z; Yu X; Yue H
J Clin Endocrinol Metab; 2023 Jun; 108(7):1768-1775. PubMed ID: 36611251
[TBL] [Abstract] [Full Text] [Related]
18. Parathyroid carcinoma during pregnancy: a novel pathogenic cdc73 mutation - a case report.
Dematapitiya C; Perera C; Pathmanathan S; Subasinghe V; Anandagoda G; Dissanayaka V; Wijenayake U; Dissanayake P; Gamage K; Wijewickrama P; Sumanatilleke M
BMC Endocr Disord; 2022 Oct; 22(1):259. PubMed ID: 36284286
[TBL] [Abstract] [Full Text] [Related]
19. Association Between Parafibromin Expression and Presence of Brown Tumors and Jaw Tumors in Patients with Primary Hyperparathyroidism: Series of Cases with Review of the Literature.
Popow M; Kaszczewska M; Góralska M; Kaszczewski P; Skwarek-Szewczyk A; Chudziński W; Jażdżewski K; Kolanowska M; Bogdańska M; Starzyńska-Kubicka A; Gałązka Z
Am J Case Rep; 2022 Oct; 23():e936135. PubMed ID: 36271606
[TBL] [Abstract] [Full Text] [Related]
20. Heterozygous
Blackburn J; Mulvey I; Nadar R; Dias RP; Saraff V; Senniappan S
J Pediatr Endocrinol Metab; 2022 Dec; 35(12):1547-1551. PubMed ID: 36177768
[TBL] [Abstract] [Full Text] [Related]
[Next]
